Fresh Wind Team Unveils Two AI Models for Cancer Immunotherapy
The interaction between tumor antigens presented by major histocompatibility complex (MHC) and T-cell receptors (TCRs) is essential for...
top of page
Search
TEAM FRESH WIND recent publication on TIL therapy clinical application
“TEAM FRESH WIND” led by Dr. Satoko Matsueda has recently published a paper tittle as. “Successful ex vivo expansion of tumor...
White House Unveils New Goals to Advance Biotechnology & Biomanufacturing
"Bold Goals for U.S. Biotechnology and Biomanufacturing" The White House has announced new goals and priorities to promote biotechnology...
Immune Monitoring Explained
Immune Monitoring and Breakthrough Immunotherapies More immunotherapies In Feb 2023, FDA granted the “breakthrough therapy designation”...
What is TIL Therapy?
A cell therapy that may cure cancers The human immune system is extremely complex. When most people think of the immune system, we think...
TIL Therapy with Superior Efficacy Than Immune Checkpoint Inhibitors in Advanced Melanoma
NEJM Paper (a Randomized Open-Label Trial) Walkthrough Treating advanced melanoma, a dangerous form of skin cancer, has become a...
In-Silico Identification of Neoantigens
Neoantigens, tumor specific antigens (TSAs), and tumor associated antigens (TAAs) are ultimate targets for cancer immunotherapies....
Organoids Explained
Late last year FDA removed the requirements for animal testing before moving into clinical testing. This is a timely move in the right...
Tumor Infiltrating Lymphocytes
Tumor infiltrating lymphocytes (TILs) are a type of immune cell that is found within a tumor. Neoantigens are a type of antigen that is...
Blog: Blog2
Blog: Text
bottom of page